You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced HNSCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • 3cycles (Toripalimab + cetuximab)
  • +2 more
  • Wuhan, Hebei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

Recruiting
  • HNSCC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • dose-reduced radiotherapy
  • Zhuhai, Guangdong, China
    Fifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • NDURE
  • Charleston, South Carolina
    Medical University of South Carolina
May 25, 2022

Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab+cisplatin + 5-fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • pembrolizumab+cisplatin + 5-FU
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Dec 26, 2022

Head and Neck Squamous Cell Carcinoma Trial in Germany (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Augsburg, BY, Germany
  • +7 more
Jun 20, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Le Havre, France
    Centre Guillaume le conquérant
Aug 18, 2022

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab-paclitaxel, cisplatin and Pembrolizumab combination
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 28, 2022

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Treatment
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

Not yet recruiting
  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
  • Phase I dose escalation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan Cancer Hospital
Apr 24, 2023

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    HNSCC Trial in Chengdu (Nituozumab)

    Recruiting
    • HNSCC
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Apr 16, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Pembrolizumab
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 25, 2022

    Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +10 more
    • Aurora, Colorado
    • +6 more
    Jan 4, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • PD-1 inhibitor+ Gemcitabine + Cisplatin
    • Zhuhai, Guangdong, China
      Fifth Affilliated Hospital of Sun Yat-sen University
    Jun 23, 2021

    Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

    Completed
    Has Results
    • Squamous Cell Carcinoma of Head and Neck
    • NDURE
    • Charleston, South Carolina
      Medical University of South Carolina
    Feb 25, 2021

    Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

    Not yet recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +3 more
    • (no location specified)
    Jul 24, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nimotuzumab Combined With Neoadjuvant Chemotherapy
    • (no location specified)
    Jun 29, 2022

    HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

    Active, not recruiting
    • HNSCC
    • Lorient, France
      Centre Hospitalier Bretagne Sud
    Mar 10, 2022

    Xerostomia Trial in Stanford (drug, radiation, other)

    Recruiting
    • Xerostomia
    • D-Limonene Gelcaps
    • +3 more
    • Stanford, California
      Stanford University
    Mar 11, 2022

    Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Oral Mucositis
    • MIT-001 plus CCRT
    • Gilbert, Arizona
    • +14 more
    Jan 27, 2022